NBGS USA carries multiple brands of Point of Care (POC) Rapid Antigen Tests for the detection of COVID-19 in a clinical setting.
- Results in 15 minutes
- Detects the nucleocapsid protein antigen from SARS-CoV-2
- Nasal Specimen sample
- FDA Emergency Use Authorization (EUA)
- CLIA Waived